Compare PATH & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PATH | BRKR |
|---|---|---|
| Founded | 2005 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 7.3B |
| IPO Year | 2021 | 2000 |
| Metric | PATH | BRKR |
|---|---|---|
| Price | $16.49 | $47.28 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 13 |
| Target Price | $15.50 | ★ $49.42 |
| AVG Volume (30 Days) | ★ 27.5M | 1.9M |
| Earning Date | 12-03-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.42% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | $1,553,111,000.00 | ★ $3,438,900,000.00 |
| Revenue This Year | $13.59 | $3.55 |
| Revenue Next Year | $9.61 | $1.49 |
| P/E Ratio | $39.65 | ★ N/A |
| Revenue Growth | ★ 10.05 | 6.10 |
| 52 Week Low | $9.38 | $28.53 |
| 52 Week High | $19.84 | $64.64 |
| Indicator | PATH | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 51.93 | 55.49 |
| Support Level | $16.33 | $47.52 |
| Resistance Level | $17.36 | $48.73 |
| Average True Range (ATR) | 0.74 | 1.56 |
| MACD | -0.10 | -0.10 |
| Stochastic Oscillator | 24.31 | 62.32 |
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.